Neoplasms

Blood and Lymph Conditions

All Conditions

Symptoms and General Pathology

Rare Diseases

Leukemia

Leukemia, Myeloid

Hematologic Neoplasms

Leukemia, Myelogenous, Chronic, BCR-ABL Positive

Neoplasms by Histologic Type

Hematologic Diseases

Myeloproliferative Disorders

Bone Marrow Diseases

Chronic Disease

Disease Attributes

Myeloid Leukemia

Chronic Graft Versus Host Disease

Chronic Myeloid Leukemia

Chronic Myeloproliferative Disorders

All Drugs and Chemicals

Amino Acids

Tyrosine Kinase Inhibitors

Tyrosine

Lise Laclautre

Anne Parry, MD

Atchroue Johnson Ansah, MD

Marc Berger, MD

Vanessa Pante, MD

Amelie Penot, MD

Aude CHARBONNIER, MD

Agnès Guerci-Bresler, MD

Ali Turhan, MD

Laurence Legros, MD

Martine Escoffre-Barbe, MD

Guillaume DENIS, MD

Denis Guyotat, MD

Françoise Huguet, MD

Philippe Rousselot, MD

Marc BERGER, MD

Establish the largest possible real-life cohort collecting long-term follow-up of a maximum number of CML patients in order to carry out observational studies: epidemiological, identification of subgroups according to their response to treatment, evaluation of new molecules in real life, therapeutic discontinuations, impact of the evolution of recommendations, etc.

Observational study collecting real-life clinico-biological data from patients with CML. Data are collected prospectively and retrospectively, from diagnosis and throughout the long-term follow-up of CML (follow up continues after treatment stopped).

Chronic Myeloid Leukemia (CML) Real-Life Database

Aims of the registry are the collection of clinical data to gain further insights about patients's CML treated with ITK's (treatment, prognosis, therapeutical response).

Centre Hospitalier Universitaire de Saint Etienne

Bicetre Hospital

University Hospital, Caen

Central Hospital, Nancy, France

University Hospital, Toulouse

CH Annecy Genevois

Rennes University Hospital

Hopital Paul Brousse

Versailles Hospital

Centre Hospitalier Emile Roux

University Hospital, Limoges

Institut Paoli-Calmettes

Centre Hospitalier de Rochefort

University Hospital, Clermont-Ferrand

Study title	NCT ID	Conditions	Interventions	Eligibility	Organization	Link
Chronic Myeloid Leukemia (CML) Real-Life Database	NCT05963061	Chronic Myeloid...		-	University Hospital, Clermont-Ferrand
Chronic Myeloid Leukemia (CML) Real-Life Database	NCT05963061	Chronic Myeloid...		-	University Hospital, Clermont-Ferrand

Spots Global Cancer Trial Database for chronic, bcr::abl positive